Increased Plasma YKL-40/Chitinase-3-Like-Protein-1 Is Associated with Endothelial Dysfunction in Obstructive Sleep Apnea

Purpose Obstructive sleep apnea (OSA) is a common disorder affecting 15–24% of the adults and is associated with increased risk of hypertension and atherosclerosis. The exact mechanisms underlying hypertension in OSA are not entirely clear. YKL-40/Chitinase-3-like protein-1 is a circulating moiety with roles in injury, repair and angiogenesis that is dysregulated in atherosclerosis and a number of other diseases. We sought to determine the role of YKL-40 in endothelial dysfunction and hypertension in OSA. Methods We studies 23 normotensive OSA (N-OSA) and 14 hypertensive OSA (H-OSA) without diabetes and apparent cardiovascular disease. Endothelial-dependent nitric oxide-mediated vasodilatory capacity was assessed by flow-mediated vasodilation (FMD). YKL-40, vascular endothelial growth factor (VEGF) and the soluble form of VEGF receptor-1or sFlt-1 were measured in plasma using ELISA methodology. Results N-OSA subjects aged 49.1±2.3 years and H-OSA aged 51.3±1.9 years with BMI 36.1±1.6 and 37.6±1.9 kg/m2, respectively. The apnea-hypopnea index (AHI) was 41±5 events/hr in N-OSA and 46±6 in H-OSA with comparable degree of oxygen desaturations during sleep. FMD was markedly impaired in H-OSA (8.3%±0.8) compared to N-OSA (13.2%±0.6, P<0.0001). Plasma YKL-40 was significantly elevated in H-OSA (55.2±7.9 ng/ml vs. 35.6±4.2 ng/ml in N-OSA, P = 0.02) and had an inverse relationship with FMD (r = −0.52, P = 0.013). There was a significant positive correlation between sFlt-1/VEGF, a measure of decreased VEGF availability, and YKL-40 (r = 0.42, P = 0.04). Conclusion The levels of plasma YKL-40 were elevated in H-OSA group and inversely correlated with the endothelial-dependent vasodilatory capacity whereas there was a positive correlation between sFlt-1/VEGF and YKL-40. These findings suggest that YKL-40 is dysregulated, in part, due to perturbation of VEGF signaling, and may contribute to endothelial dysfunction and hypertension in OSA.

[1]  Hisashi Adachi,et al.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[2]  Y. Modis,et al.  Chitinase 3-like 1 Regulates Cellular and Tissue Responses via IL-13 Receptor α2 , 2013, Cell reports.

[3]  J. Hilden,et al.  Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial. , 2013, Immunobiology.

[4]  V. Mohsenin,et al.  Activation of heme oxygenase and suppression of cGMP are associated with impaired endothelial function in obstructive sleep apnea with hypertension. , 2012, American journal of hypertension.

[5]  L. Køber,et al.  The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure. , 2012, Immunobiology.

[6]  Yan Zhang,et al.  Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension , 2012, BMC Cardiovascular Disorders.

[7]  E. Keshet,et al.  Vascular endothelial growth factor and vascular homeostasis. , 2011, Proceedings of the American Thoracic Society.

[8]  H. Vestergaard,et al.  YKL-40 levels are independently associated with albuminuria in type 2 diabetes , 2011, Cardiovascular Diabetology.

[9]  V. Mohsenin,et al.  Circulating antiangiogenic proteins in obstructive sleep apnea and hypertension. , 2011, Respiratory medicine.

[10]  G. Frühbeck,et al.  Increased circulating and visceral adipose tissue expression levels of YKL-40 in obesity-associated type 2 diabetes are related to inflammation: impact of conventional weight loss and gastric bypass. , 2011, The Journal of clinical endocrinology and metabolism.

[11]  R. Shao,et al.  Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of Glioblastoma* , 2011, The Journal of Biological Chemistry.

[12]  S. Bojesen,et al.  Elevated plasma YKL‐40 levels and ischemic stroke in the general population , 2010, Annals of neurology.

[13]  H. Vestergaard,et al.  Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population. , 2010, International journal of cardiology.

[14]  J. Concato,et al.  Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death , 2010, Sleep and Breathing.

[15]  H. Vestergaard,et al.  YKL-40 - an emerging biomarker in cardiovascular disease and diabetes , 2009, Cardiovascular diabetology.

[16]  H. Yaggi,et al.  The effect of gender on the prevalence of hypertension in obstructive sleep apnea. , 2009, Sleep medicine.

[17]  J. Kastrup,et al.  High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease. , 2009, European heart journal.

[18]  A. Malhotra,et al.  Endothelial function in obstructive sleep apnea. , 2009, Progress in cardiovascular diseases.

[19]  V. Castronovo,et al.  Experimental anti‐angiogenesis causes upregulation of genes associated with poor survival in glioblastoma , 2007, International journal of cancer.

[20]  G. Saade,et al.  The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. , 2007, American journal of obstetrics and gynecology.

[21]  J. Concato,et al.  Obstructive sleep apnea as a risk factor for stroke and death. , 2005, The New England journal of medicine.

[22]  L. Bortolotto,et al.  Early signs of atherosclerosis in obstructive sleep apnea. , 2005, American journal of respiratory and critical care medicine.

[23]  M. Wolzt,et al.  Circulating plasma levels of vascular endothelial growth factor in patients with sleep disordered breathing. , 2004, Respiratory medicine.

[24]  M. G. Modena,et al.  Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. , 2004, Journal of the American College of Cardiology.

[25]  P. Ganz,et al.  Role of Endothelial Dysfunction in Atherosclerosis , 2004, Circulation.

[26]  T. Libermann,et al.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. , 2003, The Journal of clinical investigation.

[27]  A. J. Millis,et al.  gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. , 2003, Experimental cell research.

[28]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[29]  N. Ferrara.  Role of vascular endothelial growth factor in regulation of physiological angiogenesis. , 2001, American journal of physiology. Cell physiology.

[30]  H. Kleinman,et al.  Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. , 1999, Experimental cell research.

[31]  C. D. de Vries,et al.  Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[32]  V. Backer,et al.  Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. , 1996, British journal of rheumatology.

[33]  L. Shackelton,et al.  Identification of a 38-kDa Heparin-binding Glycoprotein (gp38k) in Differentiating Vascular Smooth Muscle Cells as a Member of a Group of Proteins Associated with Tissue Remodeling (*) , 1995, The Journal of Biological Chemistry.

[34]  T. Young,et al.  The occurrence of sleep-disordered breathing among middle-aged adults. , 1993, The New England journal of medicine.

[35]  S. Karumanchi,et al.  In vivo rat model of preeclampsia. , 2006, Methods in molecular medicine.

[36]  C W Whitney,et al.  Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. , 2001, American journal of respiratory and critical care medicine.

[37]  Erry,et al.  Prospective study of the association between sleep-disordered breathing and hypertension. , 2000, The New England journal of medicine.